Mozambique is preparing to introduce Lenacapavir, a long-acting injectable medication for the prevention of HIV infection, starting in January 2026. Health authorities expect to initially acquire between 80,000 and 90,000 doses, with the treatment aimed at 30,000 to 40,000 people in high-risk groups. The announcement was made by Francisco Mbofana, Executive Secretary of the National… Continue reading Mozambique to Introduce HIV Prevention Injection Lenacapavir in 2026